Neonatal vaccine effectiveness and the role of adjuvants

References

• WHO, PMNCH. Newborn death and illness. Partnership for Maternal, Newborn & Child Health, News and Media Centre Fact sheets. http://www.who.int/pmnch/media/press_materials/fs/fs_newborndealth_illness/en/, (2011).
   Google Scholar
• Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2015;385(9966):430–440.
   PubMed Web of Science ®Google Scholar
• WHO. Vaccines against influenza WHO position paper - november 2012. Wkly Epidemiol Rec. 2012;87(47):461–476.
   PubMedGoogle Scholar
• Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355(1):31–40.
   PubMed Web of Science ®Google Scholar
• Poehling KA, Edwards KM, Griffin MR, et al. The burden of influenza in young children, 2004–2009. Pediatrics. 2013;131(2):207–216.
   PubMed Web of Science ®Google Scholar
• Coffin SE, Zaoutis TE, Rosenquist ABW, et al. Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics. 2007;119(4):740–748.
   PubMed Web of Science ®Google Scholar
• Ampofo K, Gesteland PH, Bender J, et al. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics. 2006;118(6):2409–2417.
   PubMed Web of Science ®Google Scholar
• Glezen WP, Taber LH, Frank AL, et al. Influenza virus infections in infants. Pediatr Infect Dis J. 1997;16(11):1065–1068.
   PubMed Web of Science ®Google Scholar
• Nair H, Brooks WA, Katz M, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet. 2011;378(9807):1917–1930.
   PubMed Web of Science ®Google Scholar
• Dudas RA, Karron RA. Respiratory syncytial virus vaccines. Clin Microbiol Rev. 1998;11(3):430–439.
   PubMed Web of Science ®Google Scholar
• Simoes EAF. Respiratory syncytial virus infection. Lancet. 1999;354(9181):847–852.
   PubMed Web of Science ®Google Scholar
• Morein B, Abusugra I, Blomqvist G. Immunity in neonates. Vet Immunol Immunopathol. 2002;87(3–4):207–213.
   PubMed Web of Science ®Google Scholar
• Siegrist CA. Neonatal and early life vaccinology. Vaccine. 2001;19(25–26):3331–3346.
   PubMed Web of Science ®Google Scholar
• Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature. 1953;172(4379):603–606.
   PubMed Web of Science ®Google Scholar
• Kollmann TR, Kampmann B, Mazmanian SK, et al. Protecting the newborn and young infant from infectious diseases: lessons from immune ontogeny. Immunity. 2017;46(3):350–363.
   PubMed Web of Science ®Google Scholar
• Basha S, Surendran N, Pichichero M. Immune responses in neonates. Expert Rev Clin Immunol. 2014;10(9):1171–1184.
   PubMed Web of Science ®Google Scholar
• Riese P, Schulze K, Ebensen T, et al. Vaccine adjuvants: key tools for innovative vaccine design. Curr Top Med Chem. 2013;13(20):2562–2580.
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, Fox CB. New generation adjuvants–from empiricism to rational design. Vaccine. 2015;33(Suppl 2):B14–20.
   PubMed Web of Science ®Google Scholar
• Savelkoul HF, Ferro VA, Strioga MM, et al. Choice and design of adjuvants for parenteral and mucosal vaccines. Vaccines (Basel). 2015;3(1):148–171.
   PubMed Web of Science ®Google Scholar
• Wilson-Welder JH, Torres MP, Kipper MJ, et al. Vaccine adjuvants: current challenges and future approaches. J Pharm Sci. 2009;98(4):1278–1316.
   PubMed Web of Science ®Google Scholar
• Coffman RL, Sher A, Seder RA. Vaccine adjuvants: putting innate immunity to work. Immunity. 2010;33(4):492–503.
   PubMed Web of Science ®Google Scholar
• Morein B, Blomqvist G, Hu K. Immune responsiveness in the neonatal period. J Comp Pathol. 2007;137(Suppl 1):S27–31.
   PubMedGoogle Scholar
• Siegrist CA, Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol. 2009;9(3):185–194.
   PubMed Web of Science ®Google Scholar
• Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007;7(5):379–390.
   PubMed Web of Science ®Google Scholar
• Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol. 2004;4(7):553–564.
   PubMed Web of Science ®Google Scholar
• Niewiesk S. Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol. 2014;5:446.
   PubMed Web of Science ®Google Scholar
• Siegrist CA. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine. 2003;21(24):3406–3412.
   PubMed Web of Science ®Google Scholar
• Siegrist CA. The challenges of vaccine responses in early life: selected examples. J Comp Pathol. 2007;137(Suppl 1):S4–9.
   PubMedGoogle Scholar
• Michaelsson J, Mold JE, McCune JM, et al. Regulation of T cell responses in the developing human fetus. J Iimmunol. 2006;176(10):5741–5748.
   PubMed Web of Science ®Google Scholar
• Fernandez MA, Puttur FK, Wang YM, et al. T regulatory cells contribute to the attenuated primary CD8+ and CD4+ T cell responses to herpes simplex virus type 2 in neonatal mice. J Iimmunol. 2008;180(3):1556–1564.
   PubMed Web of Science ®Google Scholar
• Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol. 2015;16:343.
   PubMed Web of Science ®Google Scholar
• Sun CM, Deriaud E, Leclerc C, et al. Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity. 2005;22(4):467–477.
   PubMed Web of Science ®Google Scholar
• Krumbiegel D, Zepp F, Meyer CU. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells. Hum Immunol. 2007;68(10):813–822.
   PubMed Web of Science ®Google Scholar
• Allen CD, Cyster JG. Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function. Semin Immunol. 2008;20(1):14–25.
   PubMed Web of Science ®Google Scholar
• MacLennan IC. Germinal centers. Annu Rev Immunol. 1994;12:117–139.
   PubMed Web of Science ®Google Scholar
• Wang X, Cho B, Suzuki K, et al. Follicular dendritic cells help establish follicle identity and promote B cell retention in germinal centers. J Exp Med. 2011;208(12):2497–2510.
   PubMed Web of Science ®Google Scholar
• Pihlgren M, Tougne C, Bozzotti P, et al. Unresponsiveness to lymphoid-mediated signals at the neonatal follicular dendritic cell precursor level contributes to delayed germinal center induction and limitations of neonatal antibody responses to T-dependent antigens. J Iimmunol. 2003;170(6):2824–2832.
   PubMed Web of Science ®Google Scholar
• Plotkin SA. Complex correlates of protection after vaccination. Clin Infect Dis. 2013;56(10):1458–1465.
   PubMed Web of Science ®Google Scholar
• Zemlin M, Hoersch G, Zemlin C, et al. The postnatal maturation of the immunoglobulin heavy chain IgG repertoire in human preterm neonates is slower than in term neonates. J Iimmunol. 2007;178(2):1180–1188.
   PubMed Web of Science ®Google Scholar
• Glezen WP. Effect of maternal antibodies on the infant immune response. Vaccine. 2003;21(24):3389–3392.
   PubMed Web of Science ®Google Scholar
• Burt TD. Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease. Am J Reprod Immunol. 2013;69(4):346–358.
   PubMed Web of Science ®Google Scholar
• Moore AC, Gallimore A, Draper SJ, et al. Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance. J Immunol. 2005;175(11):7264–7273.
   PubMed Web of Science ®Google Scholar
• Ho P, Wei X, Seah GT. Regulatory T cells induced by Mycobacterium chelonae sensitization influence murine responses to bacille Calmette-Guérin. J Leukoc Biol. 2010;88(6):1073–1080.
   PubMed Web of Science ®Google Scholar
• Flanagan KL, Halliday A, Burl S, et al. The effect of placental malaria infection on cord blood and maternal immunoregulatory responses at birth. Eur J Immunol. 2010;40(4):1062–1072.
   PubMed Web of Science ®Google Scholar
• Walther B, Miles DJ, Waight P, et al. Placental malaria is associated with attenuated CD4 T-cell responses to tuberculin PPD 12 months after BCG vaccination. BMC Infect Dis. 2012;12(1):6.
   PubMedGoogle Scholar
• Kollmann TR, Levy O, Montgomery RR, et al. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity. 2012;37(5):771–783.
   PubMed Web of Science ®Google Scholar
• CDC. Flu-related hospitalizations and deaths in the United States from April 2009 – january 30, 2010. 2010. Available from 2019 Feb 7 https://www.cdc.gov/h1n1flu/hosp_deaths_ahdra.htm
   Google Scholar
• Zaghouani H, Hoeman CM, Adkins B. Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol. 2009;30(12):585–591.
   PubMed Web of Science ®Google Scholar
• Marchant A, Goetghebuer T, Ota MO, et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Iimmunol. 1999;163(4):2249–2255.
   PubMed Web of Science ®Google Scholar
• Ravn P, Boesen H, Pedersen BK, et al. Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guerin. J Iimmunol. 1997;158(4):1949–1955.
   PubMed Web of Science ®Google Scholar
• Mascart F, Verscheure V, Malfroot A, et al. Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses. J Immunol. 2003;170(3):1504–1509.
   PubMed Web of Science ®Google Scholar
• Huygens A, Lecomte S, Tackoen M, et al. Functional exhaustion limits CD4+ and CD8+ T-cell responses to congenital cytomegalovirus infection. J Infect Dis. 2015;212(3):484–494.
   PubMed Web of Science ®Google Scholar
• Snapper C, Paul WE. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science. 1987;236(4804):944–947.
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145–173.
   PubMed Web of Science ®Google Scholar
• Harada Y, Tanaka S, Motomura Y, et al. The 3ʹ enhancer CNS2 is a critical regulator of interleukin-4-mediated humoral immunity in follicular helper T cells. Immunity. 2012;36(2):188–200.
   PubMed Web of Science ®Google Scholar
• Luthje K, Kallies A, Shimohakamada Y, et al. The development and fate of follicular helper T cells defined by an IL-21 reporter mouse. Nat Immunol. 2012;13(5):491–498.
   PubMed Web of Science ®Google Scholar
• Vijayanand P, Seumois G, Simpson LJ, et al. Interleukin-4 production by follicular helper T cells requires the conserved Il4 enhancer hypersensitivity site V. Immunity. 2012;36(2):175–187.
   PubMed Web of Science ®Google Scholar
• Yusuf I, Kageyama R, Monticelli L, et al. Germinal center T follicular helper cell IL-4 production is dependent on signaling lymphocytic activation molecule receptor (CD150). J Iimmunol. 2010;185(1):190–202.
   PubMed Web of Science ®Google Scholar
• Dullaers M, Li D, Xue Y, et al. A T cell-dependent mechanism for the induction of human mucosal homing immunoglobulin A-secreting plasmablasts. Immunity. 2009;30(1):120–129.
   PubMed Web of Science ®Google Scholar
• Tsuji M, Komatsu N, Kawamoto S, et al. Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer’s patches. Science. 2009;323(5920):1488–1492.
   PubMed Web of Science ®Google Scholar
• Hieshima K, Kawasaki Y, Hanamoto H, et al. CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells. J Iimmunol. 2004;173(6):3668–3675.
   PubMed Web of Science ®Google Scholar
• Kunkel EJ, Kim CH, Lazarus NH, et al. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J Clin Invest. 2003;111(7):1001–1010.
   PubMed Web of Science ®Google Scholar
• Debock I, Jaworski K, Chadlaoui H, et al. Neonatal follicular Th cell responses are impaired and modulated by IL-4. J Iimmunol. 2013;191(3):1231–1239.
   PubMed Web of Science ®Google Scholar
• Mastelic B, Kamath AT, Fontannaz P, et al. Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvants. J Iimmunol. 2012;189(12):5764–5772.
   PubMed Web of Science ®Google Scholar
• Sarzotti M, Robbins DS, Hoffman PM. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science. 1996;271(5256):1726–1728.
   PubMed Web of Science ®Google Scholar
• Fadel SA, Ozaki DA, Sarzotti M. Enhanced type 1 immunity after secondary viral challenge in mice primed as neonates. J Iimmunol. 2002;169(6):3293–3300.
   PubMed Web of Science ®Google Scholar
• Hunt DW, Huppertz HI, Jiang HJ, et al. Studies of human cord blood dendritic cells: evidence for functional immaturity. Blood. 1994;84(12):4333–4343.
   PubMed Web of Science ®Google Scholar
• Heldwein KA, Liang MD, Andresen TK, et al. TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG. J Leukoc Biol. 2003;74(2):277–286.
   PubMed Web of Science ®Google Scholar
• Pompei L, Jang S, Zamlynny B, et al. Disparity in IL-12 release in dendritic cells and macrophages in response to Mycobacterium tuberculosis is due to use of distinct TLRs. J Iimmunol. 2007;178(8):5192–5199.
   PubMed Web of Science ®Google Scholar
• Demirjian A, Levy O. Safety and efficacy of neonatal vaccination. Eur J Immunol. 2009;39(1):36–46.
   PubMed Web of Science ®Google Scholar
• Price DN, Kusewitt DF, Lino CA, et al. Oral tolerance to environmental mycobacteria interferes with intradermal, but not pulmonary, immunization against tuberculosis. PLoS Pathog. 2016;12(5):e1005614.
   PubMed Web of Science ®Google Scholar
• Wong VC, Ip HM, Reesink HW, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet. 1984;1(8383):921–926.
   PubMed Web of Science ®Google Scholar
• Xu Z-Y, Liu C-B, Francis DP, et al. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial. Pediatrics. 1985;76(5):713–718.
   PubMed Web of Science ®Google Scholar
• Gerlich WH. Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives. Med Microbiol Immunol. 2015;204(1):39–55.
   PubMed Web of Science ®Google Scholar
• Greenberg DP. Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies. Pediatr Infect Dis J. 1993;12(5):438–445.
   PubMed Web of Science ®Google Scholar
• WHO. In International travel and health > Vaccines > Poliomyelitis (Polio). Available from 2019 February 4th. https://www.who.int/ith/vaccines/polio/en/
   Google Scholar
• el-Sayed N, el-Gamal Y, Abbassy AA, et al. Monovalent type 1 oral poliovirus vaccine in newborns. N Engl J Med. 2008;359(16):1655–1665.
   PubMed Web of Science ®Google Scholar
• Philbin VJ, Levy O. Immunostimulatory activity of Toll-like receptor 8 agonists towards human leucocytes: basic mechanisms and translational opportunities. Biochem Soc Trans. 2007;35(6):1485–1491.
   PubMedGoogle Scholar
• Whittaker E, Goldblatt D, McIntyre P, et al. Neonatal immunization: rationale, current state, and future prospects. Front Immunol. 2018 Apr 4;9:532. doi: 10.3389/fimmu.2018.00532. eCollection 2018.
   PubMed Web of Science ®Google Scholar
• Provenzano RW, Wetterlow LH, Sullivan CL. Immunization and antibody response in the newborn infant. I. Pertussis inoculation within twenty-four hours of birth. N Engl J Med. 1965;273(18):959–965.
   PubMed Web of Science ®Google Scholar
• Locht C. Pertussis: acellular, whole-cell, new vaccines, what to choose? Expert Rev Vaccines. 2016;15(6):671–673.
   PubMed Web of Science ®Google Scholar
• Locht C, Mielcarek N. New pertussis vaccination approaches: en route to protect newborns? FEMS Immunol Med Microbiol. 2012;66(2):121–133.
   PubMedGoogle Scholar
• Saleh E, Eichner B, Clark DW, et al. Open-label pilot study to compare the safety and immunogenicity of pentavalent rotavirus vaccine (RV5) administered on an early alternative dosing schedule with those of RV5 administered on the recommended standard schedule. J Pediatric Infect Dis Soc. 2017;7(1):82–85.
   Web of Science ®Google Scholar
• Siegrist CA. Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunization. J Pediatr. 2008;153(3):305–307.
   PubMed Web of Science ®Google Scholar
• Wood N, Siegrist CA. Neonatal immunization: where do we stand? Curr Opin Infect Dis. 2011;24(3):190–195.
   PubMed Web of Science ®Google Scholar
• Halasa NB, O’Shea A, Shi JR, et al. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr. 2008;153(3):327–332.
   PubMed Web of Science ®Google Scholar
• Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375(9725):1545–1555.
   PubMed Web of Science ®Google Scholar
• Review on Antimicrobial Resistance. Tackling drug-resistant infections globally: final report and recommendations. (2016). May 2016. Available from https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf
   Google Scholar
• Meissner HC, Rennels MB. Unpredictable patterns of viral respiratory disease in children. Pediatrics. 2004;113(6):1814–1816.
   PubMed Web of Science ®Google Scholar
• Brodzinski H, Ruddy RM. Review of new and newly discovered respiratory tract viruses in children. Pediatr Emerg Care. 2009;25(5):352–360; quiz 361–353.
   PubMed Web of Science ®Google Scholar
• Nichol KL, Treanor JJ. Vaccines for seasonal and pandemic influenza. J Infect Dis. 2006;194(Suppl 2):S111–118.
   PubMedGoogle Scholar
• Fiore AE, Bridges CB, Cox NJ. Seasonal influenza vaccines. Curr Top Microbiol Immunol. 2009;333:43–82.
   PubMedGoogle Scholar
• Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP), 2010. MMWR Recomm Rep. 2010;59(RR–8):1–62.
   PubMedGoogle Scholar
• Vesikari T. Emerging data on the safety and efficacy of influenza vaccines in children. Pediatr Infect Dis J. 2008;27(11 Suppl):S159–161.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Smith HM, et al. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age. Pediatrics. 2008;121(3):e568–573.
   PubMed Web of Science ®Google Scholar
• Groothuis JR, Levin MJ, Rabalais GP, et al. Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics. 1991;87(6):823–828.
   PubMed Web of Science ®Google Scholar
• Chin J, Magoffin RL, Shearer LA, et al. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol. 1969;89(4):449–463.
   PubMed Web of Science ®Google Scholar
• Murphy BR, Prince GA, Walsh EE, et al. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J Clin Microbiol. 1986;24(2):197–202.
   PubMed Web of Science ®Google Scholar
• Kim HW, Canchola JG, Brandt CD, et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol. 1969;89(4):422–434.
   PubMed Web of Science ®Google Scholar
• Graham BS, Henderson GS, Tang YW, et al. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Iimmunol. 1993;151(4):2032–2040.
   PubMed Web of Science ®Google Scholar
• Knudson CJ, Hartwig SM, Meyerholz DK, et al. RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets. PLoS Pathog. 2015;11(3):e1004757.
   PubMed Web of Science ®Google Scholar
• Netea MG, Van der Meer JW, Sutmuller RP, et al. From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias. Antimicrob Agents Chemother. 2005;49(10):3991–3996.
   PubMed Web of Science ®Google Scholar
• Sharma AA, Jen R, Kan B, et al. Impaired NLRP3 inflammasome activity during fetal development regulates IL-1β production in human monocytes. Eur J Immunol. 2015;45(1):238–249.
   PubMed Web of Science ®Google Scholar
• Corbett NP, Blimkie D, Ho KC, et al. Ontogeny of toll-like receptor mediated cytokine responses of human blood mononuclear cells. PloS One. 2010;5(11):e15041.
   PubMed Web of Science ®Google Scholar
• Morris MC, Neonatal Vaccination: SN. Challenges and Intervention Strategies. Neonatology. 2016;109(3):161–169.
   PubMed Web of Science ®Google Scholar
• Ganapathi L, Van Haren S, Dowling DJ, et al. The imidazoquinoline toll-like receptor-7/8 agonist hybrid-2 potently induces cytokine production by human newborn and adult leukocytes. PloS One. 2015;10(8):e0134640.
   PubMed Web of Science ®Google Scholar
• Kim D, Niewiesk S. Synergistic induction of interferon α through TLR-3 and TLR-9 agonists stimulates immune responses against measles virus in neonatal cotton rats. Vaccine. 2014;32(2):265–270.
   PubMed Web of Science ®Google Scholar
• Honda-Okubo Y, Ong CH, Petrovsky N. Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protection. Vaccine. 2015;33(38):4892–4900.
   PubMed Web of Science ®Google Scholar
• Dowling DJ, van Haren SD, Scheid A, et al. TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth. JCI Insight. 2017;2(6):e91020.
   PubMed Web of Science ®Google Scholar
• Vono M, Eberhardt CS, Mohr E, et al. Overcoming the neonatal limitations of inducing germinal centers through liposome-based adjuvants including C-type lectin agonists trehalose dibehenate or curdlan. Front Immunol. 2018 Feb 28;9:381. doi: 10.3389/fimmu.2018.00381. eCollection 2018.
   PubMed Web of Science ®Google Scholar
• Blondheim O, Bader D, Abend M, et al. Immunogenicity of hepatitis B vaccine in preterm infants. Arch Dis Child Fetal Neonatal Ed. 1998;79(3):F206–208.
   PubMed Web of Science ®Google Scholar
• Golebiowska M, Kardas-Sobantka D, Chlebna-Sokol D, et al. Hepatitis B vaccination in preterm infants. Eur J Pediatr. 1999;158(4):293–297.
   PubMed Web of Science ®Google Scholar
• Saari TN. American academy of pediatrics committee on infectious d. immunization of preterm and low birth weight infants. American academy of pediatrics committee on infectious diseases. Pediatrics. 2003;112(1Pt 1)):193–198.
   PubMedGoogle Scholar
• Freitas Da Motta MS, Mussi-Pinhata MM, Jorge SM, et al. Immunogenicity of hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life. Vaccine. 2002;20(11–12):1557–1562.
   PubMed Web of Science ®Google Scholar
• Mastelic Gavillet B, Eberhardt CS, Auderset F, et al. MF59 mediates its B cell adjuvanticity by promoting T follicular helper cells and thus germinal center responses in adult and early life. J Iimmunol. 2015;194(10):4836–4845.
   PubMed Web of Science ®Google Scholar
• van Haren SD, Dowling DJ, Foppen W, et al. Age-specific adjuvant synergy: dual TLR7/8 and mincle activation of human newborn dendritic cells enables Th1 polarization. J Immunol. 2016;197(11):4413–4424.
   PubMed Web of Science ®Google Scholar
• Kamath AT, Mastelic B, Christensen D, et al. Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses. J Immunol. 2012;188(10):4828–4837.
   PubMed Web of Science ®Google Scholar
• Lemoine S, Jaron B, Tabka S, et al. Dectin-1 activation unlocks IL12A expression and reveals the TH1 potency of neonatal dendritic cells. J Allergy Clin Immunol. 2015;136(5):1355–1368.e1315.
   PubMed Web of Science ®Google Scholar
• Nohmi K, Tokuhara D, Tachibana D, et al. Zymosan induces immune responses comparable with those of adults in monocytes, dendritic cells, and monocyte-derived dendritic cells from cord blood. J Pediatr. 2015;167(1):155–162.e151–152.
   PubMed Web of Science ®Google Scholar
• Cooper PD, Petrovsky N. Delta inulin: a novel, immunologically active, stable packing structure comprising beta-D-[2 -> 1] poly(fructo-furanosyl) alpha-D-glucose polymers. Glycobiology. 2011;21(5):595–606.
   PubMed Web of Science ®Google Scholar
• Petrovsky N, Cooper PD. Advax, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety. Vaccine. 2015;33(44):5920–5926.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Aoshi T, Haseda Y, et al. Advax, a delta inulin microparticle, potentiates in-built adjuvant property of co-administered vaccines. EBioMedicine. 2017;15:127–136.
   PubMed Web of Science ®Google Scholar
• Counoupas C, Pinto R, Nagalingam G, et al. Delta inulin-based adjuvants promote the generation of polyfunctional CD4(+) T cell responses and protection against Mycobacterium tuberculosis infection. Sci Rep. 2017;7(1):8582.
   PubMedGoogle Scholar
• Li L, Honda-Okubo Y, Li C, et al. Delta inulin adjuvant enhances plasmablast generation, expression of activation-induced cytidine deaminase and B-cell affinity maturation in human subjects receiving seasonal influenza vaccine. PloS One. 2015;10(7):e0132003.
   PubMed Web of Science ®Google Scholar
• Honda-Okubo Y, Barnard D, Ong CH, et al. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology. J Virol. 2014;89(6):2995–3007.
   PubMed Web of Science ®Google Scholar
• Andersen P, Doherty TM. The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat Rev Microbiol. 2005;3(8):656–662.
   PubMed Web of Science ®Google Scholar
• Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97–107.
   PubMed Web of Science ®Google Scholar
• Levy O, Suter EE, Miller RL, et al. Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Blood. 2006;108(4):1284–1290.
   PubMed Web of Science ®Google Scholar
• Philbin VJ, Dowling DJ, Gallington LC, et al. Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1–dependent pathways. J Allergy Clin Immunol. 2012;130(1):195–204.e199.
   PubMed Web of Science ®Google Scholar
• Dowling DJ, Tan Z, Prokopowicz ZM, et al. The ultra-potent and selective TLR8 agonist VTX-294 activates human newborn and adult leukocytes. PloS One. 2013;8(3):e58164.
   PubMed Web of Science ®Google Scholar
• Surendran N, Simmons A, Pichichero ME. TLR agonist combinations that stimulate Th type I polarizing responses from human neonates. Innate Immun. 2018;24(4):240–251.
   PubMed Web of Science ®Google Scholar
• Pulendran B. Systems vaccinology: probing humanity’s diverse immune systems with vaccines. Proc Natl Acad Sci U S A. 2014;111(34):12300–12306.
   PubMed Web of Science ®Google Scholar
• Hagan T, Nakaya HI, Subramaniam S, et al. Systems vaccinology: enabling rational vaccine design with systems biological approaches. Vaccine. 2015;33(40):5294–5301.
   PubMed Web of Science ®Google Scholar
• Zhang W, Li F, Nie L. Integrating multiple ‘omics’ analysis for microbial biology: application and methodologies. Microbiology. 2010;156(Pt 2):287–301.
   PubMedGoogle Scholar
• Nakaya HI, Wrammert J, Lee EK, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol. 2011;12(8):786–795.
   PubMed Web of Science ®Google Scholar
• Amenyogbe N, Levy O, Kollmann TR. Systems vaccinology: a promise for the young and the poor. Philos Trans R Soc Lond B Biol Sci. 2015;370(1671):20140340.
   PubMed Web of Science ®Google Scholar
• Blohmke CJ, O’Connor D, Pollard AJ. The use of systems biology and immunological big data to guide vaccine development. Genome Med. 2015;7(1):114.
   PubMedGoogle Scholar